Grey Nuns Community Hospital, Edmonton, AB, Canada.
Division of Cardiology, University of Alberta, Edmonton, AB, Canada.
Medicine (Baltimore). 2022 Sep 9;101(36):e30470. doi: 10.1097/MD.0000000000030470.
Depression has been associated with adverse outcomes in patients with cardiac disease. Data on its prevalence and the factors influencing it are limited in the cardiac rehabilitation program (CRP) setting. To elucidate the prevalence of and the factors that influence depression in patients attending CRP. Patients attending the CRP from 2003 to 2016 were included in the study. All patients had a Beck Depression Inventory-II (BDI-II) performed prior to commencement in CRP and were followed longitudinally. The BDI-II for the 4989 patients were as follows: 0 to 13 (normal) = 3623 (72%); 14 to 19 (mild depression) = 982 (20%); 20 to 28 (moderate depression) = 299 (6%); 29 to 63 (severe depression) = 85 (2%). The BDI-II (mean ± SEM) for males (mean age: 60.8 ± 0.1 years) and females (mean age: 63.4 ± 0.3 years, P < .001) were 7.0 ± 0.1 and 8.5 ± 0.2 (P < .001), respectively. Elevated BDI-II scores (14-63) were more common in type 1 (41.1%) and type 2 (30.5%) diabetics than nondiabetics (25.7%). Similarly, elevated scores were more common in smokers (36.1%) than never-smokers (24.7%). The BDI-II scores for Caucasians, South Asians, and East Asians were 7.3 ± 0.1, 8.0 ± 0.3, and 7.0 ± 0.3 respectively (P = .01 for CA vs SA by 1-way ANOVA and least significant difference test). The prevalence of depression is high in patients attending CRP affecting 28% of the population. BDI-II is a simple validated screening tool that can be applied to patients attending CRP. Diabetics, current smokers, and South Asians all had a higher prevalence of depression.
抑郁症与心脏病患者的不良结局有关。在心脏康复计划(CRP)环境中,有关其患病率和影响因素的数据有限。为了阐明在参加 CRP 的患者中抑郁症的患病率和影响因素。本研究纳入了 2003 年至 2016 年期间参加 CRP 的患者。所有患者在开始 CRP 前均进行贝克抑郁量表第二版(BDI-II)检查,并进行了纵向随访。4989 例患者的 BDI-II 结果如下:0 至 13(正常)=3623(72%);14 至 19(轻度抑郁)=982(20%);20 至 28(中度抑郁)=299(6%);29 至 63(重度抑郁)=85(2%)。男性(平均年龄:60.8±0.1 岁)和女性(平均年龄:63.4±0.3 岁,P<.001)的 BDI-II(平均值±SEM)分别为 7.0±0.1 和 8.5±0.2(P<.001)。1 型(41.1%)和 2 型(30.5%)糖尿病患者的 BDI-II 评分(14-63)高于非糖尿病患者(25.7%)。同样,在吸烟者(36.1%)中,评分升高的比例高于从不吸烟者(24.7%)。白种人、南亚人和东亚人的 BDI-II 评分分别为 7.3±0.1、8.0±0.3 和 7.0±0.3(单因素方差分析和最小显著差异检验显示,CA 与 SA 之间 P=.01)。在参加 CRP 的患者中,抑郁症的患病率很高,影响了 28%的人群。BDI-II 是一种简单有效的筛查工具,可用于接受 CRP 的患者。糖尿病患者、当前吸烟者和南亚人患抑郁症的比例更高。